Cochrane Abstracts
Daratumumab and antineoplastic therapy versus antineoplastic therapy only for people with newly diagnosed multiple myeloma ineligible for transplant
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Daratumumab and Antineoplastic Therapy Versus Antineoplastic Therapy Only for People With Newly Diagnosed Multiple Myeloma Ineligible for Transplant." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436447/all/Daratumumab_and_antineoplastic_therapy_versus_antineoplastic_therapy_only_for_people_with_newly_diagnosed_multiple_myeloma_ineligible_for_transplant_New. Accessed 17 April 2024.
Daratumumab and antineoplastic therapy versus antineoplastic therapy only for people with newly diagnosed multiple myeloma ineligible for transplant. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436447/all/Daratumumab_and_antineoplastic_therapy_versus_antineoplastic_therapy_only_for_people_with_newly_diagnosed_multiple_myeloma_ineligible_for_transplant_New. Accessed April 17, 2024.
Daratumumab and antineoplastic therapy versus antineoplastic therapy only for people with newly diagnosed multiple myeloma ineligible for transplant. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/436447/all/Daratumumab_and_antineoplastic_therapy_versus_antineoplastic_therapy_only_for_people_with_newly_diagnosed_multiple_myeloma_ineligible_for_transplant_New
Daratumumab and Antineoplastic Therapy Versus Antineoplastic Therapy Only for People With Newly Diagnosed Multiple Myeloma Ineligible for Transplant [Internet]. In: Cochrane Abstracts. [cited 2024 April 17]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436447/all/Daratumumab_and_antineoplastic_therapy_versus_antineoplastic_therapy_only_for_people_with_newly_diagnosed_multiple_myeloma_ineligible_for_transplant_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Daratumumab and antineoplastic therapy versus antineoplastic therapy only for people with newly diagnosed multiple myeloma ineligible for transplant
ID - 436447
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436447/all/Daratumumab_and_antineoplastic_therapy_versus_antineoplastic_therapy_only_for_people_with_newly_diagnosed_multiple_myeloma_ineligible_for_transplant_New
DB - Evidence Central
DP - Unbound Medicine
ER -
